v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash Flows from Operating Activities        
Net loss $ (5,191,042) $ (2,518,084) $ (6,410,564) $ (4,306,918)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock based compensation 468,219 682,978 838,358 67,586
Accrued interest 467,193 315,978 698,990 364,879
Gain (loss) on extinguishment of debt 1,045,346 565,453 1,744,906 1,842,273
Fair value of stock issued for note modification 2,572,517 410,008 2,082,423 449,660
Amortization of debt discount 28,497
Changes in operating assets and liabilities:        
Prepaid expenses and other assets 86,885 4,073 (82,812) 39,129
Accounts payable and accrued expenses 228,836 183,388 629,283 764,583
Net cash used in operating activities (322,046) (356,206) (499,416) (750,311)
Cash Flows from Investing Activities:        
Net cash provided by (used in) investing activities
Cash Flows from Financing Activities        
Proceeds from convertible notes 195,000 345,000 105,000
Proceeds from convertible notes – related party 155,000 135,000 105,000
Proceeds from promissory notes 225,000 770,831
Proceeds from promissory notes – related party 45,000 10,000
Proceeds from options exercise 54,270    
Repayment of promissory notes (225,000)
Net cash provided by financing activities 324,270 350,000 490,000 755,831
Net increase (decrease) in cash 2,224 (6,206) (9,416) 5,520
Cash, beginning of period 3,480 12,896 12,896 7,376
Cash, end of period 5,704 6,690 3,480 12,896
Supplemental disclosures:        
Interest paid
Cash paid for income taxes    
Supplemental disclosures of non-cash items:        
Promissory notes issued with no cash proceeds 856,354    
Common stock issued for note modification $ 2,572,517    
Accounts payable and accrued payable exchanged for convertible note     $ 234,200 $ 440,129